Impact of Ureteral Stent and Sheaths Size on Post-Operative Pain
Launched by MAYO CLINIC · May 13, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how the size of ureteral stents, which are small tubes placed in the urinary system, affects pain and discomfort after surgery. Specifically, the study will focus on patients who are having a procedure called retrograde intra-renal surgery (RIRS) to treat kidney stones. The goal is to find out if using different sizes of stents can make a difference in how much pain patients feel after their surgery.
To be eligible for this trial, patients need to be between the ages of 65 and 74 and must be undergoing RIRS specifically for stone treatment. However, patients with certain conditions, like injuries during the procedure or those who are pregnant, will not be included. If you participate in the trial, you can expect to have a stent placed after your surgery, and researchers will monitor your pain levels to see how the size of the stent affects your recovery experience. This study is not yet recruiting participants, but it aims to help improve post-operative care for patients undergoing kidney stone surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Patients undergoing a retrograde intra-renal surgery (RIRS) (only patients undergoing the procedure for stone treatment will be included) who will require post-operative indwelling ureteral stent placement on a string at the conclusion of the procedure.
- Exclusion Criteria:
- • Patients with intra-operative ureteral injury who will require ureteral stent for extended time (more than 10 days, in that case a stent without a string will be used).
- • Patient undergoing ureteroscopy for any indication other than stone extraction.
- • Patients who are currently pregnant as determined by clinical presurgical screening.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Meghan A. Cooper, DO
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported